End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.32 CNY | -1.12% | +6.87% | -45.61% |
Apr. 26 | Hinova Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | China Stocks Fall Ahead of March Economic Data Release | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.8B 20.34B |
---|---|---|---|---|---|
Net income 2024 * | -472M -3.42B | Net income 2025 * | 83M 602M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.94
x | P/E ratio 2025 * |
33.3
x | Employees | 181 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.28% |
1 day | -1.12% | ||
1 week | +6.87% | ||
Current month | -6.38% | ||
1 month | +1.69% | ||
3 months | -24.01% | ||
6 months | -46.39% | ||
Current year | -45.61% |
Managers | Title | Age | Since |
---|---|---|---|
Xing Hai Li
FOU | Founder | 61 | 13-02-04 |
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 13-02-04 |
Ze Yan Shi
DFI | Director of Finance/CFO | 43 | 21-11-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yuan Wei Chen
CEO | Chief Executive Officer | 61 | 13-02-04 |
Xing Hai Li
FOU | Founder | 61 | 13-02-04 |
Yuan Lun Chen
BRD | Director/Board Member | 54 | 20-09-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 28.32 | -1.12% | 940,346 |
24-06-13 | 28.64 | +1.34% | 647,702 |
24-06-12 | 28.26 | +0.75% | 644,972 |
24-06-11 | 28.05 | +5.85% | 679,017 |
24-06-07 | 26.5 | +0.88% | 647,553 |
End-of-day quote Shanghai S.E., June 13, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.61% | 386M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- 688302 Stock